Ab Trill serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Ab Trill has executed 7 insider transactions totaling $7.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 25, 2025 involved purchasing 73,099 shares valued at $626.5K.
Ab Trill currently holds 8,825,742 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ab Trill has been a net buyer of DMAC stock. They have purchased $7.6M and sold $0 worth of shares.
Ab Trill's most recent insider trade was on Nov 25, 2025, when they purchased 73,099 shares at $8.57 per share.
Get notified when new Form 4 filings are submitted
| $7.89 |
| Discretionary |
| Nov 21, 2025 | DMAC | $1.5M | Purchase | 208,872 | $7.41 | Discretionary |
| Nov 20, 2025 | DMAC | $951.6K | Purchase | 128,426 | $7.41 | Discretionary |
| Nov 19, 2025 | DMAC | $1.7M | Purchase | 240,352 | $7.21 | Discretionary |
| Nov 18, 2025 | DMAC | $1.2M | Purchase | 182,882 | $6.75 | Discretionary |
| Nov 17, 2025 | DMAC | $1.2M | Purchase | 187,393 | $6.52 | Discretionary |